Report Categories
View AllRecent Articles
View All
Exel Stock Analysis Exelixis Inc Gains 2.68 To Hit 44.04 Key Biotech Price Level 20260401
Vcel Stock Analysis Vericel Corporation 4.85 Gain 34.14 Performance Outlook 20260403
Tpta Stock Analysis Terra Property Trust 2026 6Pct Notes Hit 21.56 After 2.67 Pct Rise 20260403 1
Crex Stock Analysis Creative Realities Inc 3.48 Usd Mild Gain Performance Review 20260401 1
Are Insiders Buying Or Selling Iqiyi Inc. Iq Stock Price At 1.26 Down 1.56 20260410
Bgl Stock Analysis Blue Gold Limited Drops 8.53 Percent To 1.18 Amid Sector Headwinds 20260403 1
Gabelli GGZ Stock Decreases Stake Trend Strengthens 20260418
PRTA Prothena Corporation plc Ordinary Shares rises 361 percent after Q4 2025 EPS outpaces analyst consensus estimates
Duke Energy DUK Stock Risk Reward Setup Buying Pressure 20260416
MSTR Strategy Inc shares rise 376 percent in Q4 2025 despite sharp EPS miss and 3 percent year over year revenue growth
GPACU General Purpose Acquisition Corp Units posts far narrower Q4 2025 loss than estimates shares notch small daily gain
HG Hamilton Insurance Group Ltd notches large Q4 2025 EPS beat over analyst estimates as its stock rises slightly
OLMA Olema Pharmaceuticals Inc posts narrow Q4 2025 EPS beat sending shares up two percent in daily trading
Market Pulse Tech outperforms as consumer sector lags broad market gains
RYDE Ryde Group Ltd reports wider than projected Q2 2025 loss as operational cost pressures weigh on quarterly performance
TVTX Travere Therapeutics delivers positive Q4 2025 earnings against consensus loss estimates shares rise 475 percent today
How Scorpio STNG thinks about risk management Scorpio posts 07 EPS beat vs consensus estimates
CFGI CitizensPref latest quarterly earnings results and corresponding stock movement data remain unreported to date
Regeneron Pharmaceuticals Inc REGN Bullish Analyst Ratings Underscore Oncology Pipeline Upside and Core Product Resilience
Is SaverOne SVREW stock exposed to external risks
BristolMyers Squibb XLV Wall Street Consensus Remains Moderate Buy Following Strong Guidance and Earnings Beats
Is COPT Defense CDP stock moving sideways Q4 2025 EPS Misses Views
Is Open LPRO stock cheap relative to earnings growth Q4 2025 Earnings Underperform
Milestone MIST Stock Valuation Gap Analysis Milestone posts 103 negative EPS surprise with no revenue reported